Detalhe da pesquisa
1.
Protocols for Co-Culture Phenotypic Assays with Breast Cancer Cells and THP-1-Derived Macrophages.
J Mammary Gland Biol Neoplasia
; 29(1): 4, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340231
2.
Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.
Proc Natl Acad Sci U S A
; 110(30): 12426-31, 2013 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23836671
3.
Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.
Arthritis Rheum
; 65(8): 2161-71, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23666743
4.
Drivers of cancer metastasis - Arise early and remain present.
Biochim Biophys Acta Rev Cancer
; 1879(2): 189060, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151195
5.
PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
Cell Chem Biol
; 31(2): 326-337.e11, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016478
6.
lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells.
Endocr Relat Cancer
; 30(8)2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130273
7.
Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease.
Cancer Lett
; 547: 215775, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667515
8.
Inhibition of the Ê-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
Cancer Lett
; 507: 13-25, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713737
9.
MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance.
Cell Death Dis
; 12(12): 1111, 2021 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839359
10.
Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study.
Sci Rep
; 10(1): 7950, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409632
11.
Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
Oncogene
; 38(15): 2860-2875, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552384
12.
Corrigendum to "Inhibition of the Ê-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors" [Canc. Lett. 507 (2021) 13-25].
Cancer Lett
; 526: 363, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872789
13.
Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.
EMBO Mol Med
; 8(2): 105-16, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26758680
14.
Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.
Cancer Res
; 76(3): 724-35, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637668
15.
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma.
Cancer Cell
; 27(1): 85-96, 2015 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500121
16.
Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors.
Nat Commun
; 5: 3901, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24849047
17.
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma.
Cancer Cell
; 31(3): 466, 2017 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292443